Search Results - "Mastrullo, L"

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party by D'Arena, G., Valentini, C.G., Pietrantuono, G., Guariglia, R., Martorelli, M.C., Mansueto, G., Villani, O., Onofrillo, D., Falcone, A., Specchia, G., Semenzato, G., Di Renzo, N., Mastrullo, L., Venditti, A., Ferrara, F., Palumbo, A., Pagano, L., Musto, P.

“…The best therapeutic approach for primary plasma cell leukemia (PPCL) remains unknown so far. In very limited studies, the poor clinical outcome of this…”
Get full text

Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy by Marrone, A., Capoluongo, N., D'Amore, C., Pisaturo, M., Esposito, M., Guastafierro, S., Siniscalchi, I., Macera, M., Boemio, A., Onorato, L., Rinaldi, L., Minichini, C., Adinolfi, L. E., Sagnelli, E., Mastrullo, L., Coppola, N.

“…Summary This study evaluated the long‐term efficacy and safety of an 18‐month lamivudine prophylaxis in 68 HBsAg‐negative/anti–HBc‐positive patients with…”
Get full text

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine by Graffigna, G., Cecchini, I., Breccia, M., Capochiani, E., Seta, R. Della, Galimberti, S., Melosi, A., Simonetti, F., Pizzuti, M., Capalbo, S. F., Falzetti, F., Mazza, P., Di Renzo, N., Mastrullo, L., Rapezzi, D., Orlandi, E., Intermesoli, T., Iurlo, A., Pungolino, E., Pacilli, M.

“…Purpose The main objective of this study is to gain a deeper understanding of how patients suffering from chronic myeloid leukemia (CML) cope with their…”
Get full text

102 IRON CHELATION THERAPY IMPROVES HAEMATOLOGICAL RESPONSE IN HIGH-RISK MYELODYSPLASTIC PATIENTS TREATED WITH AZACITIDINE by Improta, S, Cioppa, P. Della, Esposito, M, Gagliardi, A, Lucania, A, Izzo, G. Nitrato, Villa, M.R, Mastrullo, L

Get full text

P-120 Risk factors in myelodysplastic syndromes (MDS): A single centre retrospective study by Improta, S, Villa, M.R, Gagliardi, A, Cioppa, P. Della, Lucania, A, Izzo, G. Nitrato, Mastrullo, L

Get full text

P-288 Azacitidine therapy in high-risk myelodysplastic syndromes (MDS): A single centre experience by Improta, S, Gagliardi, A, Villa, M.R, Cioppa, P. Della, Esposito, M, Izzo, G. Nitrato, Mastrullo, L

Get full text

352 Iron overload in low-risk myelodysplastic syndromes (MDS): A multicentric study by Improta, S, Villa, M.R, Volpe, A, Sanpaolo, G, Spinosa, G, Farina, G, Cantore, N, Cascavilla, N, Capalbo, S, Storti, S, Mastrullo, L

Get full text

P066 WT1 expression in patients with myelodysplastic syndromes by Polistina, M.T, Tiberio, C, Sagristani, M, Esposito, M, Improta, S, Lucania, A, Villa, M.R, Mastrullo, L

Get full text

PO017 Deferiprone is useful in blood by Russolillo, S, Nitrato Izzo, G, Esposito, M, Improta, S, Lucania, A, Villa, M.R, Mastrullo, L

Get full text

Concomitant occurrence of a primary renal NHL and of a papillary urothelial ureter cancer by Sagristani, M, Caraglia, M, Villa, M R, Lucania, A, Esposito, M, Petriccione, L, Improta, S, Marra, M, Iannaci, G, Rossiello, R, Mastrullo, L

“…In this manuscript for the first time we describe the concomitant diagnosis of primary renal non-Hodgkin lymphoma (PRL) and of a papillary urothelial cancer in…”
Get more information

Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates by de Biasi, R, Rocino, A, Papa, M L, Salerno, E, Mastrullo, L, De Blasi, D

“…Very-high-purity Factor VIII concentrates produced by monoclonal or recombinant technology have been postulated to be more antigenic resulting in an increased…”
Get more information

Aeromonas sobria sepsis in a neutropenic patient by Orlando, R, Mastrullo, L, De Blasi, D, Boffa, M L, Zorzato, G, Miraglia, E

Get full text

The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs : a randomized, prospective, two-year comparison with an intermediate purity concentrate by DE BIASI, R, ROCINO, A, MIRAGLIA, E, MASTRULLO, L, QUIRINO, A. A

“…Pathophysiologic considerations as well as non-comparative clinical results suggest that very high purity concentrates may slow immunologic deterioration in…”
Get full text

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study) by Musto, Pellegrino, Simeon, Vittorio, Cascavilla, Nicola, Falcone, Antonietta, Petrucci, Maria Teresa, Cesini, Laura, Di Raimondo, Francesco, Conticello, Concetta, Ria, Roberto, Catalano, Lucio, Salvatore, Dalila, Mastrullo, Lucia, Gagliardi, Alfredo, Villani, Oreste, Pietrantuono, Giuseppe, D’Arena, Giovanni, Mansueto, Giovanna, Bringhen, Sara, Genuardi, Mariella, Di Renzo, Nicola, Reddiconto, Giovanni, Fragasso, Alberto, Caravita, Tommaso, Scapicchio, Daniele, Marziano, Gioacchino, Boccadoro, Mario, Mangiacavalli, Silvia, Corso, Alessandro

“…Therapeutic re-challenge is currently a debated issue in the field of multiple myeloma (MM), given the recent availability of several new drugs and…”
Get full text

Acute Promyelocytic Leukemia in Patients Aged Over 60 Years: Multicenter Experience of 34 Consecutive Unselected Patients by FERRARA, Felicetto, FINIZIO, Olimpia, D'ARCO, Alfonso, MASTRULLO, Lucia, CANTORE, Nicola, MUSTO, Pellegrino

“…Treatment of acute promyelocytic leukemia (APL) has evolved over recent years, resulting in a cure rate of 75-80%. However, the prognosis of older patients…”
Get full text

Combined administration of darbepoetin and zoledronic acid in the treatment of refractory multiple myeloma (MM) by Improta, S., Caraglia, M., Lucania, A., Sagristani, M., Villa, M.R., Budillon, A., Mastrullo, L.

Get full text

AIDS and hemophilia by de Biasi, R, Rocino, A, Miraglia, E, Mastrullo, L, Carola, A

Get more information

Molecular evidences of single mutational events followed by recurrent crossing-overs in the common δ-globin alleles in the Mediterranean area by Lacerra, Giuseppina, Musollino, Gennaro, Scarano, Clelia, Lagona, Laura F., Caruso, Daniela G., Testa, Rosario, Prezioso, Romeo, Di Noce, Francesca, Medulla, Emilia, Friscia, Maria G., Mastrullo, Lucia, Caldora, Mercedes, Nota, Lucia, Gaudiano, Carlo, Magnano, Carmelo, Ciaccio, Calogero, Romeo, Maria A., Carestia, Clementina

“…The human δ-globin gene (HBD) is one of the β-like globin genes expressed in adults. In the Mediterranean countries the carriers of δ-thalassemia defects or Hb…”
Get full text

Epidemiology of the delta globin alleles in southern Italy shows complex molecular, genetic, and phenotypic features by Angioletti, Maria De, Lacerra, Giuseppina, Gaudiano, Carlo, Mastrolonardo, Gabriella, Pagano, Leonilde, Mastrullo, Lucia, Masciandaro, Santa, Carestia, Clementina

“…We characterized mutations and haplotypes of the δ‐globin gene (HBD, MIM# 142000) in two regions of southern Italy. Mutations were discovered by screening for…”
Get full text

Liver disease in hemophiliacs: etiological and biochemical data on 159 cases from our geographical area by Ruggiero, G, Cesaro, G, Mazzella, C, Gaeta, G B, Miraglia, E, Mastrullo, L, Boffa, M L, Spiteri, D, Schiattarella, V, de Biasi, R

“…A total of 159 hemophiliacs (149 treated) from our geographical area were screened in 1983 for serological evidence of HBV infection and biochemical evidence…”
Get more information